Search

everythinglearnresearchcommunity

for

Search:↓

Long-term use of Risperidone may be linked to a serious skin condition in bipolar patients, affecting their overall well-being.

The study found two new mutations in a Chinese patient with severe biotinidase deficiency.

rTMS may help treat trichotillomania in some patients.

Androgens like testosterone may help treat traumatic brain injury by reducing mitochondrial stress and inflammation.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Early recognition and management of gastrointestinal tuberculosis in lupus patients are crucial to prevent complications.

The meeting discussed medical findings, including benefits of certain treatments for cancer and heart conditions, and highlighted issues like poor adherence to preventive measures and skill gaps among interns.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.

A child with trichothiodystrophy also had autoimmune thyroiditis and anemia, which is a new finding.

The report expanded knowledge of MBTPS1-related disorders by identifying new symptoms.

A new genetic variant causes trichothiodystrophy in two brothers, but their mother may carry it without showing symptoms.

Remote photobiomodulation improves brain injury outcomes and behavior in rats.

A woman with a unique syndrome similar to TRPS has a genetic change near the TRPS1 gene, affecting its regulation.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

Patients with traumatic brain injury need comprehensive care to improve their well-being.

Inconsistent safety reporting in chronic back pain trials risks patient safety and decision-making.

Ritlecitinib is safe and may effectively treat alopecia areata.

Early detection and biotin treatment improve outcomes for biotinidase deficiency.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

The Bethesda system is effective for identifying thyroid cancer but has low sensitivity.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Stereotactic body radiation therapy and radiosurgery are advanced, precise treatments that target tumors while protecting healthy tissue.

4-(Ethoxycarbophenyl) retinamide is much less toxic than other retinoids.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Early diagnosis of Trichorhinophalangeal syndrome type 1 is crucial for treatment and was achieved through clinical examination and family history.

Trichotillomania can occur in unusual patterns and sites, highlighting the need for awareness and treatment options.